147 related articles for article (PubMed ID: 6791053)
1. Valproic acid and secondary hyperammonemia.
Rawat S; Borkowski WJ; Swick HM
Neurology; 1981 Sep; 31(9):1173-4. PubMed ID: 6791053
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures.
Gal P; Oles KS; Gilman JT; Weaver R
Neurology; 1988 Mar; 38(3):467-71. PubMed ID: 3126410
[TBL] [Abstract][Full Text] [Related]
3. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
Castro-Gago M; Gómez-Lado C; Eirís-Puñal J; Díaz-Mayo I; Castiñeiras-Ramos DE
J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
[TBL] [Abstract][Full Text] [Related]
4. Differential ammonia decay kinetics indicates more than one concurrent etiological mechanism for symptomatic hyperammonemia caused by valproate overdose.
Mojumder DK; De Oleo RR
Indian J Pharmacol; 2014; 46(3):345-7. PubMed ID: 24987188
[TBL] [Abstract][Full Text] [Related]
5. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic hyperammonemia in patients receiving valproic acid.
Murphy JV; Marquardt K
Arch Neurol; 1982 Sep; 39(9):591-2. PubMed ID: 6810855
[TBL] [Abstract][Full Text] [Related]
7. Valproate-induced coma: case report and literature review.
Duarte J; Macias S; Coria F; Fernandez E; Clavería LE
Ann Pharmacother; 1993 May; 27(5):582-3. PubMed ID: 8347908
[TBL] [Abstract][Full Text] [Related]
8. Hyperammonemia following intravenous valproate loading.
DeWolfe JL; Knowlton RC; Beasley MT; Cofield S; Faught E; Limdi NA
Epilepsy Res; 2009 Jul; 85(1):65-71. PubMed ID: 19299111
[TBL] [Abstract][Full Text] [Related]
9. Valproate use associated with persistent hyperammonemia and mitochondrial injury in a child with Down's syndrome.
Kane RE; Kotagel S; Bacon BR; Vogler CA
J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):223-7. PubMed ID: 1534366
[TBL] [Abstract][Full Text] [Related]
10. Gait instability in valproate-treated patients: Call to measure ammonia levels.
Kipervasser S; Elger CE; Korczyn AD; Nass RD; Quesada CM; Neufeld MY
Acta Neurol Scand; 2017 Nov; 136(5):401-406. PubMed ID: 28436001
[TBL] [Abstract][Full Text] [Related]
11. [Hyperammonemia in valproate therapy in children and adolescents].
Laub MC
Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
[TBL] [Abstract][Full Text] [Related]
12. Fatal hyperammonemia in a patient with systemic lupus erythematosus.
Ichikawa H; Amano T; Kawabata K; Kushiro M; Wada J; Nagake Y; Makino H
Intern Med; 1998 Aug; 37(8):700-3. PubMed ID: 9745859
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid-induced hyperammonemia: a case report.
McCall M; Bourgeois JA
J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
[TBL] [Abstract][Full Text] [Related]
14. Blood ammonia level during valproic acid therapy.
Kugoh T; Yamamoto M; Hosokawa K
Jpn J Psychiatry Neurol; 1986 Dec; 40(4):663-8. PubMed ID: 3110472
[TBL] [Abstract][Full Text] [Related]
15. Nondosage-dependent valproic acid-induced hyperammonemia and coma.
Gaskins JD; Holt RJ; Postelnick M
Clin Pharm; 1984; 3(3):313-6. PubMed ID: 6428801
[No Abstract] [Full Text] [Related]
16. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
[TBL] [Abstract][Full Text] [Related]
17. L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.
Maldonado C; Guevara N; Silveira A; Fagiolino P; Vázquez M
J Int Med Res; 2017 Jun; 45(3):1268-1272. PubMed ID: 28425821
[TBL] [Abstract][Full Text] [Related]
18. Hyperammonemia with valproic acid therapy.
Coulter DL; Allen RJ
J Pediatr; 1981 Aug; 99(2):317-9. PubMed ID: 6788925
[No Abstract] [Full Text] [Related]
19. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
Mallet L; Babin S; Morais JA
Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
[TBL] [Abstract][Full Text] [Related]
20. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
